Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Do galectins serve as soluble ligands for immune checkpoint receptors? | J Immunother Cancer | 2024 | 38599662 | PubTator, text mining | PubMed |
| PPIscreenML: Structure-based screening for protein-protein interactions using AlphaFold. | bioRxiv | 2024 | 38559274 | PubTator, text mining | PubMed |
| Methods for generating the CD137L-DC-EBV-VAX anti-cancer vaccine. | Methods Cell Biol | 2024 | 38548412 | PubTator, text mining | PubMed |
LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study. | Lancet Oncol | 2024 | 38547893 | PubTator, text mining | PubMed |
| Identification of immune cell-related prognostic genes characterized by a distinct microenvironment in hepatocellular carcinoma. | World J Clin Oncol | 2024 | 38455128 | PubTator, text mining | PubMed |
| Results of a phase I trial with Haploidentical mbIL-21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML. | Am J Hematol | 2024 | 38444268 | PubTator, text mining | PubMed |
| CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy. | Blood | 2024 | 38437725 | PubTator, text mining | PubMed |
| Author Correction: T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection. | Nat Med | 2024 | 38418853 | PubTator, text mining | PubMed |
| Multi-omic profiling reveals associations between the gut microbiome, host genome and transcriptome in patients with colorectal cancer. | J Transl Med | 2024 | 38369542 | PubTator, text mining | PubMed |
| Ferroptosis mediated by TNFSF9 interferes in acute ischaemic stroke reperfusion injury with the progression of acute ischaemic stroke. | J Neurochem | 2024 | 38344886 | PubTator, text mining | PubMed |
| DNA damage response alterations in clear cell renal cell carcinoma: clinical, molecular, and prognostic implications. | Eur J Med Res | 2024 | 38326910 | PubTator, text mining | PubMed |
| Exploration of neuron heterogeneity in human heart failure with dilated cardiomyopathy through single-cell RNA sequencing analysis. | BMC Cardiovasc Disord | 2024 | 38310240 | PubTator, text mining | PubMed |
| APOB is a potential prognostic biomarker in hepatocellular carcinoma. | Discov Oncol | 2024 | 38310202 | PubTator, text mining | PubMed |
| Macrophage barrier in the tumor microenvironment and potential clinical applications. | Cell Commun Signal | 2024 | 38279145 | PubTator, text mining | PubMed |
| Rapamycin as a Potential Alternative Drug for Squamous Cell Gingiva Carcinoma (Ca9-22): A Focus on Cell Cycle, Apoptosis and Autophagy Genetic Profile. | Pharmaceuticals (Basel) | 2024 | 38276004 | PubTator, text mining | PubMed |
| SLCO4A1, as a novel prognostic biomarker of non‑small cell lung cancer, promotes cell proliferation and migration. | Int J Oncol | 2024 | 38275113 | PubTator, text mining | PubMed |
| Single-cell N6-methyladenosine-related genes function within the tumor microenvironment to affect the prognosis and treatment sensitivity in patients with gastric cancer. | Cancer Cell Int | 2024 | 38273348 | PubTator, text mining | PubMed |
| Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity. | Nat Commun | 2024 | 38267413 | PubTator, text mining | PubMed |
| Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co-Stimulatory Molecules for Cancer Immunotherapy. | Molecules | 2024 | 38257366 | PubTator, text mining | PubMed |
| Antimicrobial and Other Pharmacological Properties of Ocimum basilicum, Lamiaceae. | Molecules | 2024 | 38257301 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=9